Intercure (INCR) - Total Liabilities

Latest as of December 2025: ILA294.19 Million ILA ≈ $788.73K USD

Based on the latest financial reports, Intercure (INCR) has total liabilities worth ILA294.19 Million ILA (≈ $788.73K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Intercure - Total Liabilities Trend (2008–2025)

This chart illustrates how Intercure's total liabilities have evolved over time, based on quarterly financial data. See Intercure current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Intercure Competitors by Total Liabilities

The table below lists competitors of Intercure ranked by their total liabilities.

Company Country Total Liabilities
Enjoei S.A
SA:ENJU3
Brazil R$133.21 Million
Culp, Inc. Common Stock
NASDAQ:CULP
USA $70.53 Million
Respiri Ltd
AU:RSH
Australia AU$2.26 Million
FRIWO AG
F:CEA
Germany €27.34 Million
TPBI PCL
BK:TPBI
Thailand ฿1.04 Billion
Diatreme Resources Ltd
AU:DRX
Australia AU$2.23 Million
Minehub Technologies Inc
V:MHUB
Canada CA$1.67 Million
Jacques Bogart SA
PA:JBOG
France €291.72 Million

Liability Composition Analysis (2008–2025)

This chart breaks down Intercure's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see INCR company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.48 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.74 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.43 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Intercure's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Intercure (2008–2025)

The table below shows the annual total liabilities of Intercure from 2008 to 2025.

Year Total Liabilities Change
2025-12-31 ILA294.19 Million
≈ $788.73K
-19.38%
2024-12-31 ILA364.90 Million
≈ $978.29K
+10.73%
2023-12-31 ILA329.55 Million
≈ $883.52K
-24.51%
2022-12-31 ILA436.53 Million
≈ $1.17 Million
+92.19%
2021-12-31 ILA227.13 Million
≈ $608.93K
+564.88%
2020-12-31 ILA34.16 Million
≈ $91.58K
+31.23%
2019-12-31 ILA26.03 Million
≈ $69.79K
+60.12%
2018-12-31 ILA16.26 Million
≈ $43.59K
+397.63%
2017-12-31 ILA3.27 Million
≈ $8.76K
-10.88%
2016-12-31 ILA3.67 Million
≈ $9.83K
+449.16%
2015-12-31 ILA667.52K
≈ $1.79K
-65.65%
2014-12-31 ILA1.94 Million
≈ $5.21K
-13.50%
2013-12-31 ILA2.25 Million
≈ $6.02K
-52.13%
2012-12-31 ILA4.69 Million
≈ $12.58K
-91.41%
2011-12-31 ILA54.64 Million
≈ $146.49K
+309.28%
2010-12-31 ILA13.35 Million
≈ $35.79K
+24.36%
2009-12-31 ILA10.73 Million
≈ $28.78K
-71.12%
2008-12-31 ILA37.17 Million
≈ $99.65K
--

About Intercure

TA:INCR Israel Drug Manufacturers - Specialty & Generic
Market Cap
$39.00 Million
ILA14.55 Billion ILA
Market Cap Rank
#22843 Global
#316 in Israel
Share Price
ILA266.00
Change (1 day)
+0.00%
52-Week Range
ILA228.00 - ILA585.00
All Time High
ILA6317.95
About

InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in… Read more